Biocryst Pharmaceuticals buy HC Wainwright

Summary

This prediction is currently active. The prediction for Biocryst Pharmaceuticals disappoints with a performance of -19.17%. This prediction currently runs until 25.02.26. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
Biocryst Pharmaceuticals	10.933%	10.933%
iShares Core DAX®	0,39 %	0,15 %
iShares Nasdaq 100	1,31 %	-2,55 %
iShares Nikkei 225®	-0,46 %	6,89 %
iShares S&P 500	1,31 %	-1,16 %